Jeff Yass’s CNS Pharmaceuticals CNSP Stock Holding History

Jeff Yass’s Portfolio CNSP Stock Details CNSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1	Closed	-$24K	–	12451
2023 Q3	$24K	Buy	+1	New	+$54.5K	﹤0.01%	11557
2022 Q1	–	Hold	0	–	-$8K	–	13081
2021 Q4	–	Hold	0	–	–	–	12952

Other funds holding CNSP

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAF

Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FWA

FSM Wealth Advisors Cleveland, Ohio $939M AUM 22.84% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jeff Yass's CNSP Position: Q4 2023 in Review

Jeff Yass sold out of CNS Pharmaceuticals (CNSP) in Q4 2023, closing a stake of 1 share — an estimated $24K sold.

Jeff Yass first reported a position in CNSP in Q3 2023 and held it in 1 quarter. The position peaked at $24K in Q3 2023. 6 funds tracked by Wall St. Rank hold CNSP as of Q4 2023.

Jeff Yass reported no remaining CNS Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Jeff Yass sold 1 CNS Pharmaceuticals share in Q4 2023, an estimated $24K.
Jeff Yass first reported a position in CNS Pharmaceuticals in Q3 2023 and held it in 1 quarter.
Jeff Yass's CNS Pharmaceuticals position peaked at $24K in Q3 2023.
6 funds tracked by Wall St. Rank held CNS Pharmaceuticals as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.